Giuseppe De Luca

Incident reporting reduction during the COVID-19 pandemic in a tertiary Italian hospital: A retrospective analysis

A. Saieva, C. Girotto, Giulia Pauletti, 2021, International journal for quality in health care : journal of the International Society for Quality in Health Care.

Renal cell carcinoma: the population, real world, and cost-of-illness

M. Rugge, M. Zorzi, V. Zagonel, 2022, BMC Urology.

Estimated Direct Costs of Renal Cancer by Stage of Disease at Diagnosis and Phase of Its Management: A Whole-Disease Model.

V. Zagonel, A. Buja, Vincenzo Baldo, 2023, Clinical genitourinary cancer.

Use of an Artificial Neural Network to Identify Patient Clusters in a Large Cohort of Patients with Melanoma by Simultaneous Analysis of Costs and Clinical Characteristics

M. Rugge, E. Grossi, M. Zorzi, 2020, Acta dermato-venereologica.

Using Failure Mode, Effect and Criticality Analysis to improve safety in the cancer treatment prescription and administration process

A. Buja, Vincenzo Baldo, A. Saieva, 2023, Journal of Pharmaceutical Policy and Practice.

Could the mitotic count improve personalized prognosis in melanoma patients?

A. Vecchiato, P. Del Fiore, S. Tropea, 2024, PloS one.

Thirty-two-year trends of cancer incidence by sex and cancer site in the Veneto Region from 1987 to 2019

S. Guzzinati, E. Bovo, Giuseppe De Luca, 2024, Frontiers in public health.